“…In accordance with our results, many previous studies have already reported that the various types of anti-parkinsonian drugs reduced TJMs induced by cholinomimetic drugs, including pilocarpine and tacrine (Correa et al, 2004;Cousins et al, 1997;Koganemaru et al, 2014;Mayorga et al, 1997;Miwa et al, 2008;Podurgiel et al, 2013;Simola et al, 2004). In the central nervous system, the main action site of such drugs has been suggested to be in the VLS (Mayorga et al, 1999b;Salamone et al, 1998;Simola et al, 2004); however, we cannot completely rule out the possible involvement of other brain areas, such as the substantia nigra pars reticulata, subthalamic nucleus, globus pallidus, pedunculopontine region, motor nucleus of the trigeminal nerve, or medial striatum (Koganemaru et al, 2014;Miwa et al, 2009). Furthermore, systemic administration of cholinomimetic drugs might induce jaw and mouth movements via unintended effects on the salivary glands and gastrointestinal tract.…”